The fate of newly synthesized V-ATPase accessory subunit Ac45 in the secretory pathway.
The vacuolar H+-ATPase (V-ATPase) is a multimeric enzyme complex that acidifies organelles of the vacuolar system in eukaryotic cells. Proteins that interact with the V-ATPase may play an important role in controlling the intracellular localization and activity of the proton pump. The neuroendocrine-enriched V-ATPase accessory subunit Ac45 may represent such a protein as it has been shown to interact with the membrane sector of the V-ATPase in only a subset of organelles. Here, we examined the fate of newly synthesized Ac45 in the secretory pathway of a neuroendocrine cell. A major portion of intact approximately 46-kDa Ac45 was found to be N-linked glycosylated to approximately 62 kDa and a minor fraction to approximately 64 kDa. Trimming of the N-linked glycans gave rise to glycosylated Ac45-forms of approximately 61 and approximately 63 kDa that are cleaved to a C-terminal fragment of 42-44 kDa (the deglycosylated form is approximately 23 kDa), and a previously not detected approximately 22-kDa N-terminal cleavage fragment (the deglycosylated form is approximately 20 kDa). Degradation of the N-terminal fragment is rapid, does not occur in lysosomes and is inhibited by brefeldin A. Both the N- and C-terminal fragment pass the medial Golgi, as they become partially endoglycosidase H resistant. The Ac45 cleavage event is a relatively slow process (half-life of intact Ac45 is 4-6 h) and takes place in the early secretory pathway, as it is not affected by brefeldin A and monensin. Tunicamycin inhibited N-linked glycosylation of Ac45 and interfered with the cleavage process, suggesting that Ac45 needs proper folding for the cleavage to occur. Together, our results indicate that Ac45 folding and cleavage occur slowly and early in the secretory pathway, and that the cleavage event may be linked to V-ATPase activation.
Schoonderwoert
Vincent Th G
VT
Department of Animal Physiology, Nijmegen Center for Molecular Life Sciences, University of Nijmegen, The Netherlands.
Jansen
Eric J R
EJ
Martens
Gerard J M
GJ
D000818:Animals; D020126:Brefeldin A / Q000494:pharmacology; D004789:Enzyme Activation; D006031:Glycosylation; D006056:Golgi Apparatus / Q000378:metabolism; D006868:Hydrolysis; D008565:Membrane Proteins / Q000737:chemistry / Q000378:metabolism*; D011233:Precipitin Tests; D021381:Protein Transport; D014415:Tunicamycin / Q000494:pharmacology; D025262:Vacuolar Proton-Translocating ATPases / Q000737:chemistry / Q000378:metabolism*; D029867:Xenopus Proteins; D014982:Xenopus laevis
C089598:ATP6AP1 protein, human; D008565:Membrane Proteins; D029867:Xenopus Proteins; C484227:atp6ap1.1 protein, Xenopus; D014415:Tunicamycin; D020126:Brefeldin A; D025262:Vacuolar Proton-Translocating ATPases